Study Assessing CLENPIQ As Bowel Preparation for Pediatric Colonoscopy

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 23, 2022

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Bowel Preparation
Interventions
DRUG

CLENPIQ

"CLENPIQ consists of sodium picosulfate 10.0 mg + magnesium oxide 3.5 g + citric acid, anhydrous 12.0 g.~Supplied as a pre-mixed, ready-to-drink oral solution in two bottles, each containing 160 mL."

DRUG

MIRALAX

MIRALAX powder for oral solution, supplied in a 8.3 oz multi-dose bottle containing 238 g of laxative powder (polyethylene glycol \[PEG\] 3350).

Trial Locations (5)

10467

RECRUITING

Ferring Investigational Site, The Bronx

21201

RECRUITING

Ferring Investigational Site, Baltimore

21287

RECRUITING

Ferring Investigational Site, Baltimore

36604

RECRUITING

Ferring Investigational Site, Mobile

92123

RECRUITING

Ferring Investigational Site, San Diego

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY